case_images: PMC11102671_01
case_images: Schematic overview of the treatment course of patient 1 (a), patient 2 (b), and patient 3 (c). Gray boxes mark inpatient treatment periods. The dotted line indicates first presentation to our clinic. Dotted boxes mark uncertain information as it was not fully reported in previous medical reports.. AZA, azathioprine; BNB baricitinib; CTX, chemotherapy; IA, immunoadsorption; IVIG, intravenous immunoglobulins; MMF, mycophenolate mofetil; MTX, methotrexate; RTX, rituximab; TAC, tacrolimus; TOF, tofacitinib.
case_images: 10.1177_1759720X241250238-fig2.jpg
case_images: PMC11102671_03_10.1177_1759720X241250238-fig2.jpg
case_images: fig2-1759720X241250238
case_images: Figure 2(c) shows the treatment course of patient 3.
case_images: PMC11102671_02
case_images: Schematic overview of the treatment course of patient 1 (a), patient 2 (b), and patient 3 (c). Gray boxes mark inpatient treatment periods. The dotted line indicates first presentation to our clinic. Dotted boxes mark uncertain information as it was not fully reported in previous medical reports.. AZA, azathioprine; BNB baricitinib; CTX, chemotherapy; IA, immunoadsorption; IVIG, intravenous immunoglobulins; MMF, mycophenolate mofetil; MTX, methotrexate; RTX, rituximab; TAC, tacrolimus; TOF, tofacitinib.
case_images: 10.1177_1759720X241250238-fig2.jpg
case_images: PMC11102671_03_10.1177_1759720X241250238-fig2.jpg
case_images: fig2-1759720X241250238
case_images: Figure 2(c) shows the treatment course of patient 3.
case_images: Skin manifestations of patient 2 with (a) heliotrope erythema, (b) Gottron papules, and (c) bilateral Holster sign.
case_images: 10.1177_1759720X241250238-fig3.jpg
case_images: PMC11102671_02_10.1177_1759720X241250238-fig3.jpg
case_images: fig3-1759720X241250238
case_images: Here, she presented with the full clinical picture of DM, including ongoing proximal muscle weakness of all extremities, numbing fatigue, recurrent angina pectoris in the morning, erythema of the face and trunk, Gottron papules, slight scaling of the digital skin, and a positive Holster sign (Figure 3).
case_images: PMC11102671_03
case_images: Schematic overview of the treatment course of patient 1 (a), patient 2 (b), and patient 3 (c). Gray boxes mark inpatient treatment periods. The dotted line indicates first presentation to our clinic. Dotted boxes mark uncertain information as it was not fully reported in previous medical reports.. AZA, azathioprine; BNB baricitinib; CTX, chemotherapy; IA, immunoadsorption; IVIG, intravenous immunoglobulins; MMF, mycophenolate mofetil; MTX, methotrexate; RTX, rituximab; TAC, tacrolimus; TOF, tofacitinib.
case_images: 10.1177_1759720X241250238-fig2.jpg
case_images: PMC11102671_03_10.1177_1759720X241250238-fig2.jpg
case_images: fig2-1759720X241250238
case_images: Figure 2(c) shows the treatment course of patient 3.